139 related articles for article (PubMed ID: 8619361)
1. Clinical experience with iobitridol 250-300 in digital subtraction angiography. Double-blind randomized studies vs. iopromide and iohexol.
Bouard JC; Lyonnet D; Illes JP; Bouard-Monnier C; Rouviere O; Pangaud C
Acta Radiol Suppl; 1996; 400():85-8. PubMed ID: 8619361
[TBL] [Abstract][Full Text] [Related]
2. Iobitridol 300 compared to iopromide 300--a double-blind randomized phase-III study of clinical tolerance in total body CT.
Hoogewoud HM; Woessmer B
Acta Radiol Suppl; 1996; 400():62-4. PubMed ID: 8619354
[TBL] [Abstract][Full Text] [Related]
3. Iobitridol 250 vs iohexol 240 in phlebography of th lower limbs. A double-blind clinical trial.
Chagnaud C; Moulin G; Bartoli JM; Rousseau H; Railhac JJ; Lyonnet D
Acta Radiol Suppl; 1996; 400():89-91. PubMed ID: 8619362
[TBL] [Abstract][Full Text] [Related]
4. Clinical tolerance and diagnostic efficacy of iobitridol 300 in lower limb angiography.
Stockx L; Wilms G; Baert AL; Terrier F
Acta Radiol Suppl; 1996; 400():72-4. PubMed ID: 8619357
[TBL] [Abstract][Full Text] [Related]
5. [Contrast media in peripheral angiography: does cost reduction mean loss of quality and safety? A reevaluation based on a randomized double-blind comparative study of ioxaglate versus iopromide].
Lammer J; Winkelbauer F; Thurnher S; Wildling R; Farres MT; Woessmer B
Rofo; 1996 May; 164(5):432-6. PubMed ID: 8634406
[TBL] [Abstract][Full Text] [Related]
6. Clinical tolerance and diagnostic efficacy of iobitridol in contrast-enhanced CT in children.
Smets A; Shaw D
Acta Radiol Suppl; 1996; 400():65-7. PubMed ID: 8619355
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of Xenetix, a new iodinated contrast agent, in pediatric angiocardiography.
Rossignol AM; Lusson JR; Chantepie A; Losay J
Acta Radiol Suppl; 1996; 400():81-4. PubMed ID: 8619360
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of iopromide in angiography: a multicenter study.
Langer M; Behrends B; Langer R; Eichstädt H; Jänicke UA
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():61-6. PubMed ID: 2568810
[TBL] [Abstract][Full Text] [Related]
9. Clinical safety and efficacy of iobitridol in urography.
Meiss L; Bakker AJ; Falke TH; Van Waes PF
Acta Radiol Suppl; 1996; 400():68-71. PubMed ID: 8619356
[TBL] [Abstract][Full Text] [Related]
10. [Acute adverse effects and complications of central venous digital subtraction angiography (DSA). Results of 2,600 studies].
Gross-Fengels W; Beyer D; Fischbach R; Lanfermann H
Med Klin (Munich); 1991 Nov; 86(11):561-5. PubMed ID: 1770895
[TBL] [Abstract][Full Text] [Related]
11. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
[TBL] [Abstract][Full Text] [Related]
12. [Undesirable side effects of contrast media during i.v. DSA--a comparison of 2 nonionic contrast media].
Gross-Fengels W; Neufang KF; Siebert C; Lanfermann H; Steinbrich W
Rontgenblatter; 1990 Apr; 43(4):144-9. PubMed ID: 2187230
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography.
Lefevre T; Funck F; Aliot E; Ethevenot B
Acta Radiol Suppl; 1996; 400():75-80. PubMed ID: 8619358
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with a nonionic, dimeric contrast medium (iotrolan) in direct and indirect arteriography: a randomized, intraindividual double-blind study in 60 patients.
Hagen B; Wenzel-Hora BI
Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():54-60. PubMed ID: 2568808
[TBL] [Abstract][Full Text] [Related]
15. Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study.
Velázquez MT; Albarrán A; Hernández F; García Tejada J; Zueco J; Andreu J; De la Torre JM; Figueroa A; Sainz F; Tascón J
Acta Cardiol; 2010 Aug; 65(4):387-94. PubMed ID: 20821930
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
[TBL] [Abstract][Full Text] [Related]
17. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
[TBL] [Abstract][Full Text] [Related]
18. Double-blind study of the safety, tolerance, and diagnostic efficacy of iopromide as compared with iopamidol and iohexol in patients requiring aortography and visceral angiography.
Faykus MH; Cope C; Athanasoulis C; Druy EM; Hedgcock M; Miller FJ; Bron K
Invest Radiol; 1994 May; 29 Suppl 1():S98-101; discussion S106. PubMed ID: 8071053
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
[TBL] [Abstract][Full Text] [Related]
20. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
Druy EM; Bettmann MA; Jeans W
Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
